Sustainability at Zuellig Pharma

Making healthcare more accessible in Asia has underpinned the Zuellig Pharma business throughout our hundred year history and has seen us grow to become one of the largest providers of healthcare services in the region. Our approach to business has always involved looking beyond immediate needs to consider the long term future of our employees, clients and customers.


With the steady progress of our transformation journey following the launch of the Zuellig Health Solutions Innovation Centre in 2016, we embarked on a journey to extend this philosophy and make sustainability an integral part of the way we run our business. This will ensure that we will continue to operate our business in a sustainable manner, maximising impact for all our key stakeholders and the communities we serve.

We recognised the importance of identifying material sustainability-related issues where we can make a real difference, coupled with a clear sustainability strategy to help us frame and communicate our ambitions. Both are important to galvanise our teams, attract the best partners to work with, and continue our journey towards a sustainable long-term future business model.

We continue to be driven by an active commitment to support, enhance and strengthen the communities we operate in.

One of the foundations of our sustainability agenda was an extensive survey we conducted with internal and external stakeholders, including manufacturers, medical providers, pharmacies and government representatives. Global, regional and in-market perspectives of all stakeholders were captured and form the basis of our sustainability priorities.

Together with a benchmarking exercise and several leadership workshops, these perspectives were shaped into our Sustainability Framework, which outlines the most important material issues where our company can make a difference. These 22 issues are grouped under four sustainability themes (pillars), which form the foundation of our approach towards sustainability. Each pillar and issue is ‘owned’ by different members of our executive and senior management teams.

Many of the 22 material sustainability issues have been part of our operating procedures for many years, in particular those relating to Setting the Highest Standards of Integrity and Nurturing Talent. We used this process to sharpen them and set longer term goals. However, several others are newer to Zuellig Pharma, in particular material issues relating to Improving Health Outcomes and Respecting the Environment.


Making healthcare more accessible has underpinned Zuellig Pharma's business throughout our hundred-year history. We seek to make sustainability an integral part of how we work towards our vision of building a healthier future for Asia.

This first sustainability report reflects our commitment to operating with the mindset of long-term value creation and with accountability, as we embark on this sustainability journey in partnership with our clients, customers, suppliers and partners.

2020 GRI Sustainability Report
2020 GRI Content Index
2021 GRI Sustainability Report
2021 GRI Content Index
2022 GRI Sustainability Report
2022 GRI Content Index


We joined the United Nations Global Compact in 2019 to bring to life our sustainability vision of building a healthier future for Asia and fulfil our mission of making healthcare more accessible. We are firmly committed to supporting the Global Compact and implementing its Ten Principles across our 13 markets.

Our first Communication on Progress outlines Zuellig Pharma’s commitments, management systems and activities in the areas of human rights, labour, environment and anti-corruption. In each of these areas, we have identified key performance indicators to measure and report annually. We recognise that sustainability is a journey and are committed to developing challenging but achievable targets for these indicators to achieve our goals.

From 2021 onwards, our Communication on Progress will be incorporated into our GRI Sustainability Report.

Download the report below.

2019 Communication on Progress
2020 Communication on Progress
2021 Communication on Progress


Zuellig Pharma believes that we have an ethical responsibility to protect the environment and comply with environmental laws and regulations. Climate change is a reality that not only affects health outcomes, but also directly impacts our mission of making healthcare accessible to the communities we serve.

Through our first Greenhouse Gas (GHG) Report, we aim to further develop our culture of transparency and accountability, and in doing so reaffirm our commitment to the immediate reduction of our carbon impact. The many initiatives launched by our different Business Units, and the passion that drives the teams that lead these efforts, illustrate the spirit of a sustainable and socially conscious company that will not shy away from its responsibilities as it strives for a better world.

Download the Report:

Zuellig Pharma Greenhouse Gas Report 2020
Zuellig Pharma Greenhouse Gas Report 2021